|
1
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mustafa M, Ahmad R, Tantry IQ, Ahmad W,
Siddiqui S, Alam M, Abbas K, Moinuddin Hassan MI, Habib S and Islam
S: Apoptosis: A comprehensive overview of signaling pathways,
morphological changes, and physiological significance and
therapeutic implications. Cells. 13:18382024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vitale I, Pietrocola F, Guilbaud E,
Aaronson SA, Abrams JM, Adam D, Agostini M, Agostinis P, Alnemri
ES, Altucci L, et al: Apoptotic cell death in disease-current
understanding of the NCCD 2023. Cell Death Differ. 30:1097–1154.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kerr JFR, Wyllie AH and Currie AR:
Apoptosis: A basic biological phenomenon with wideranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nössing C and Ryan KM: 50 Years on and
still very much alive: ‘Apoptosis: A basic biological phenomenon
with wide-ranging implications in tissue kinetics’. Br J Cancer.
128:426–431. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tang HL, Yuen KL, Tang HM and Fung MC:
Reversibility of apoptosis in cancer cells. Br J Cancer.
100:118–122. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang HL, Tang HM, Mak KH, Hu S, Wang SS,
Wong KM, Wong CS, Wu HY, Law HT, Liu K, et al: Cell survival, DNA
damage, and oncogenic transformation after a transient and
reversible apoptotic response. Mol Biol Cell. 23:2240–2252. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nano M, Mondo JA, Harwood J, Balasanyan V
and Montell DJ: Cell survival following direct executioner-caspase
activation. Proc Natl Acad Sci USA. 120:e22165311202023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang HM and Tang HL: Anastasis: Recovery
from the brink of cell death. R Soc Open Sci. 5:1804422018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reiter RJ, Sharma R, Manucha W, Balduini
W, Loh D, Spandidos DA, Romero A, Georgakopoulou VE and Zhu W:
Mechanistic insights into the role of melatonin in cancer cell
chemoresistance. Biocell. 49:2033–2067. 2025. View Article : Google Scholar
|
|
11
|
Reiter RJ, Mayo JC, Tan D, Sainz RM,
Alatorre-Jimenez M and Qin L: Melatonin as an antioxidant: Under
promises but over delivers. J Pineal Res. 61:253–278. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Doonan F and Cotter TG: Morphological
assessment of apoptosis. Methods. 44:200–204. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Messam CA and Pittman RN: Asynchrony and
commitment to die during apoptosis. Exp Cell Res. 238:389–398.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brunet CL, Gunby RH, Benson RS, Hickman
JA, Watson AJ and Brady G: Commitment to cell death measured by
loss of clonogenicity is separable from the appearance of apoptotic
markers. Cell Death Differ. 5:107–115. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chipuk JE, Bouchier-Hayes L and Green DR:
Mitochondrial outer membrane permeabilization during apoptosis: The
innocent bystander scenario. Cell Death Differ. 13:1396–1402. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bhola PD and Letai A: Mitochondria-judges
and executioners of cell death sentences. Mol Cell. 61:695–704.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suhaili SH, Karimian H, Stellato M, Lee TH
and Aguilar MI: Mitochondrial outer membrane permeabilization: A
focus on the role of mitochondrial membrane structural
organization. Biophys Rev. 9:443–457. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tait SWG and Green DR: Mitochondrial
regulation of cell death. Cold Spring Harb Perspect Biol.
5:a0087062013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Julien O and Wells JA: Caspases and their
substrates. Cell Death Differ. 24:1380–1389. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ichim G, Lopez J, Ahmed SU, Muthalagu N,
Giampazolias E, Delgado ME, Haller M, Riley JS, Mason SM, Athineos
D, et al: Limited mitochondrial permeabilization causes DNA damage
and genomic instability in the absence of cell death. Mol Cell.
57:860–872. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roux J, Hafner M, Bandara S, Sims JJ,
Hudson H, Chai D and Sorger PK: Fractional killing arises from
cell-to-cell variability in overcoming a caspase activity
threshold. Mol Syst Biol. 11:8032015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang HL, Tang HM, Hardwick JM and Fung MC:
Strategies for tracking anastasis, a cell survival phenomenon that
reverses apoptosis. J Vis Exp. 519642015.PubMed/NCBI
|
|
23
|
Tang HM, Talbot CC Jr, Fung MC and Tang
HL: Molecular signature of anastasis for reversal of apoptosis.
F1000Res. 6:432017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun G, Guzman E, Balasanyan V, Conner CM,
Wong K, Zhou HR, Kosik KS and Montell DJ: A molecular signature for
anastasis, recovery from the brink of apoptotic cell death. J Cell
Biol. 216:3355–3368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Berthenet K, Castillo Ferrer C, Fanfone D,
Popgeorgiev N, Neves D, Bertolino P, Gibert B, Hernandez-Vargas H
and Ichim G: Failed apoptosis enhances melanoma cancer cell
aggressiveness. Cell Rep. 31:1077312020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Los M, Mozoluk M, Ferrari D, Stepczynska
A, Stroh C, Renz A, Herceg Z, Wang ZQ and Schulze-Osthoff K:
Activation and caspase-mediated inhibition of PARP: A molecular
switch between fibroblast necrosis and apoptosis in death receptor
signaling. Mol Biol Cell. 13:978–988. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X: The expanding role of mitochondria
in apoptosis. Genes Dev. 15:2922–1933. 2001.PubMed/NCBI
|
|
28
|
Liu X, He Y, Li F, Huang Q, Kato TA, Hall
RP and Li CY: Caspase-3 promotes genetic instability and
carcinogenesis. Mol Cell. 58:284–296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cao K, Riley JS, Heilig R, Montes-Gómez
AE, Vringer E, Berthenet K, Cloix C, Elmasry Y, Spiller DG, Ichim
G, et al: Mitochondrial dynamics regulate genome stability via
control of caspase-dependent DNA damage. Dev Cell. 57:1211–1225.e6.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang SS, Xie X, Wong CST, Choi Y and Fung
MC: HepG2 cells recovered from apoptosis show altered drug
responses and invasiveness. Hepatobiliary Pancreat Dis Int.
13:293–300. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu Y, So C, Lam HM, Fung MC and Tsang SY:
Apoptosis reversal promotes cancer stem cell-like cell formation.
Neoplasia. 20:295–303. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3978. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vasileva MH, Bennemann A, Zachmann K,
Schön MP, Frank J and Ulaganathan VK: CD24 flags anastasis in
melanoma cells. Apoptosis. 30:1–15. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang MR, Guo JY, Wang D and Xu N:
Identification of CD24 as a marker for tumorigenesis of melanoma.
Onco Targets Ther. 11:3401–3406. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li W, Ma H, Zhang J, Zhu L, Wang C and
Yang Y: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem
cell markers in tumorigenesis and metastasis. Sci Rep. 7:138562017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Knowles O, Doldan P, Hillier-Richardson I,
Lunetto S, Lunt S, Youssef G, Gammon L, Mackenzie IC, Philpott MP,
Rizvi H, et al: A CD24+CD271+ melanoma cancer
stem cell possesses hybrid characteristics of its single marker
counterparts and promotes invasion and therapeutic resistance. BMC
Biol. 23:2352025. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hüser L, Altevogt P and Utikal J: Role of
STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive
resistance towards targeted therapies. Oncotarget. 10:1662–1663.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang R, Wang Y, Liu X, Liu M, Sun L, Pan
X, Hu H, Jiang B, Zou Y, Liu Q, et al: Anastasis enhances
metastasis and chemoresistance of colorectal cancer cells through
upregulating cIAP2/NFκB signaling. Cell Death Dis. 14:3882023.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mehrotra S, Languino LR, Raskett CM,
Mercurio AM, Dohi T and Altieri DC: IAP regulation of metastasis.
Cancer Cell. 17:53–64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kenneth NS and Duckett CS: IAP proteins:
Regulators of cell migration and development. Curr Opin Cell Biol.
24:871–875. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Albeck JG, Burke JM, Aldridge BB, Zhang M,
Lauffenburger DA and Sorger PK: Quantitative analysis of pathways
controlling extrinsic apoptosis in single cells. Mol Cell.
30:11–25. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lovric MM and Hawkins CJ: TRAIL treatment
provokes mutations in surviving cells. Oncogene. 29:5048–5060.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zaitceva V, Kopeina GS and Zhivotovsky B:
Anastasis: Return journey from cell death. Cancers (Basel).
13:36712021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lerner AB, Case JD, Takahashi Y, Lee TH
and Mori W: Isolation of melatonin, the pineal gland factor that
lightens melanocytes1. J Am Chem Soc. 80:25871958.
View Article : Google Scholar
|
|
45
|
Lerner AB, Case JD and Heinzelman RV:
Structure of melatonin. J Am Chem Soc. 81:6084–6085. 1959.
View Article : Google Scholar
|
|
46
|
Gastel JA, Roseboom PH, Rinaldi PA, Weller
JL and Klein DC: Melatonin production: Proteasomal proteolysis in
serotonin N-acetyltransferase regulation. Science. 279:1358–1360.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cipolla-Neto J and Amaral FGD: Melatonin
as a hormone: New physiological and clinical insights. Endocr Rev.
39:990–1028. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Reiter RJ: The melatonin rhythm: Both a
clock and a calendar. Experientia. 49:654–664. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Acuña-Castroviejo D, Escames G, Venegas C,
Díaz-Casado ME, Lima-Cabello E, López LC, Rosales-Corral S, Tan DX
and Reiter RJ: Extrapineal melatonin: Sources, regulation, and
potential functions. Cell Mol Life Sci. 71:2997–3025. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cardinali DP and Rosner JM: Retinal
localization of the hydroxyindole-O-methyl transferase (HIOMT) in
the rat. Endocrinology. 89:301–303. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Vlahakes GJ and Wurtman RJ: A Mg
2+ dependent hydroxyindole O-methyltransferase in rat
Harderian gland. Biochim Biophys Acta. 261:194–197. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Raikhlin NT, KvetnoyI M and Tolkschev VN:
Melatonin may be synthesised in enterochromaffin cells. Nature.
255:344–345. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Reiter RJ, Sharma R, Tan DX, Chuffa LGA,
da Silva DGH, Slominski AT, Steinbrink K and Kleszczynski K: Dual
sources of melatonin and evidence for different primary functions.
Front Endocrinol (Lausanne). 15:14144632024. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Venegas C, García JA, Escames G, Ortiz F,
López A, Doerrier C, García-Corzo L, López LC, Reiter RJ and
Acuña-Castroviejo D: Extrapineal melatonin: Analysis of its
subcellular distribution and daily fluctuations. J Pineal Res.
52:217–227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Suofu Y, Li W, Jean-Alphonse FG, Jia J,
Khattar NK, Li J, Baranov SV, Leronni D, Mihalik AC, He Y, et al:
Dual role of mitochondria in producing melatonin and driving GPCR
signaling to block cytochrome c release. Proc Natl Acad Sci USA.
114:E7997–E8006. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhao D, Yu Y, Shen Y, Liu Q, Zhao Z,
Sharma R and Reiter RJ: Melatonin synthesis and function:
Evolutionary history in animals and plants. Front Endocrinol
(Lausanne). 10:2492019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Tan D, Manchester LC, Liu X,
Rosales-Corral SA, Acuna-Castroviejo D and Reiter RJ: Mitochondria
and chloroplasts as the original sites of melatonin synthesis: A
hypothesis related to melatonin's primary function and evolution in
eukaryotes. J Pineal Res. 54:127–138. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
He C, Wang J, Zhang Z, Yang M, Li Y, Tian
X, Ma T, Tao J, Zhu K, Song Y, et al: Mitochondria synthesize
melatonin to ameliorate its function and improve mice oocyte's
quality under in vitro conditions. Int J Mol Sci. 17:9392016.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Reiter RJ, Sharma R, Rosales-Corral S,
Manucha W, Chuffa LGA and Zuccari DAPC: Melatonin and pathological
cell interactions: Mitochondrial glucose processing in cancer
cells. Int J Mol Sci. 22:124942021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Reiter RJ, Sharma R, Rodriguez C, Martin
V, Rosales-Corral S, Zuccari DAPC and Chuffa LGA: Part-time cancers
and role of melatonin in determining their metabolic phenotype.
Life Sci. 278:1195972021. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Reiter RJ: Melatonin: Clinical relevance.
Best Pract Res Clin Endocrinol Metab. 17:273–285. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Reiter RJ, Tan DX, Paredes SD and
Fuentes-Broto L: Beneficial effects of melatonin in cardiovascular
disease. Ann Med. 42:276–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Liu J, Clough SJ, Hutchinson AJ,
Adamah-Biassi EB, Popovska-Gorevski M and Dubocovich ML: MT1 and
MT2 melatonin receptors: A therapeutic perspective. Annu Rev
Pharmacol Toxicol. 56:361–383. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Reiter RJ, Tan DX and Galano A: Melatonin:
Exceeding expectations. Physiology (Bethesda). 29:325–333.
2014.PubMed/NCBI
|
|
65
|
Martín M, Macías M, Escames G, León J and
Acuña-Castroviejo D: Melatonin but not vitamins C and E maintains
glutathione homeostasis in t-butyl hydroperoxide-induced
mitochondrial oxidative stress. FASEB J. 14:1677–1679. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Hardeland R: Antioxidative protection by
melatonin: Multiplicity of mechanisms from radical detoxification
to radical avoidance. Endocrine. 27:119–130. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Leon J, Acuña-Castroviejo D, Sainz RM,
Mayo JC, Tan DX and Reiter RJ: Melatonin and mitochondrial
function. Life Sci. 75:765–790. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
León J, Acuña-Castroviejo D, Escames G,
Tan DX and Reiter RJ: Melatonin mitigates mitochondrial
malfunction. J Pineal Res. 38:1–9. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Acuna-Castroviejo D, Escames G, Rodriguez
MI and Lopez LC: Melatonin role in the mitochondrial function.
Front Biosci. 12:947–963. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
70
|
Jou MJ, Peng TI, Yu PZ, Jou SB, Reiter RJ,
Chen JY, Wu HY, Chen CC and Hsu LF: Melatonin protects against
common deletion of mitochondrial DNA-augmented mitochondrial
oxidative stress and apoptosis. J Pineal Res. 43:389–403. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Daum G: Lipids of mitochondria. Biochim
Biophys Acta. 822:1–42. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Paradies G, Paradies V, Ruggiero FM and
Petrosillo G: Role of cardiolipin in mitochondrial function and
dynamics in health and disease: Molecular and pharmacological
aspects. Cells. 8:7282019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Fuentes J and Morcillo P: The role of
cardiolipin in mitochondrial function and neurodegenerative
diseases. Cells. 13:6092024. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Galano A, Tan DX and Reiter R: Melatonin:
A versatile protector against oxidative DNA damage. Molecules.
23:5302018. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sliwinski T, Rozej W, Morawiec-Bajda A,
Morawiec Z, Reiter R and Blasiak J: Protective action of melatonin
against oxidative DNA damage: Chemical inactivation versus
base-excision repair. Mutat Res. 634:220–227. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Liu R, Fu A, Hoffman AE, Zheng T and Zhu
Y: Melatonin enhances DNA repair capacity possibly by affecting
genes involved in DNA damage responsive pathways. BMC Cell Biol.
14:12013. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Liu W, van Pelt AMM and Hamer G: Melatonin
suppresses cancer cell proliferation, DNA repair and expression of
the oncogene TRIP13. Cell Death Discov. 11:4892025. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Liu W, Lei Q, van Pelt AMM and Hamer G:
Repeated ionizing radiation exposure induces TRIP13 expression,
conferring radioresistance in lung cancer cells. Sci Rep.
15:9852025. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Rustom A, Saffrich R, Markovic I, Walther
P and Gerdes HH: Nanotubular highways for intercellular organelle
transport. Science. 303:1007–1010. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Abounit S and Zurzolo C: Wiring through
tunneling nanotubes-from electrical signals to organelle transfer.
J Cell Sci. 125:1089–1098. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Luchetti F, Carloni S, Nasoni MG, Reiter
RJ and Balduini W: Tunneling nanotubes and mesenchymal stem cells:
New insights into the role of melatonin in neuronal recovery. J
Pineal Res. 73:e128002022. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Shanmughapriya S, Langford D and
Natarajaseenivasan K: Inter and Intracellular mitochondrial
trafficking in health and disease. Ageing Res Rev. 62:1011282020.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Liu K, Ji K, Guo L, Wu W, Lu H, Shan P and
Yan C: Mesenchymal stem cells rescue injured endothelial cells in
an in vitro ischemia-reperfusion model via tunneling nanotube like
structure-mediated mitochondrial transfer. Microvasc Res. 92:10–18.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Islam MN, Das SR, Emin MT, Wei M, Sun L,
Westphalen K, Rowlands DJ, Quadri SK, Bhattacharya S and
Bhattacharya J: Mitochondrial transfer from bone-marrow-derived
stromal cells to pulmonary alveoli protects against acute lung
injury. Nat Med. 18:759–765. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wang H, Liu C, Zhao Y and Gao G:
Mitochondria regulation in ferroptosis. Eur J Cell Biol.
99:1510582020. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Tang HM and Tang HL: Cell recovery by
reversal of ferroptosis. Biol Open. 8:bio0431822019. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Zhang D, Jia X, Lin D and Ma J: Melatonin
and ferroptosis: Mechanisms and therapeutic implications. Biochem
Pharmacol. 218:1159092023. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Cao Y, Lu C, Beeraka NM, Efetov S, Enikeev
M, Fu Y, Yang X, Basappa B, He M and Li Z: Exploring the
relationship between anastasis and mitochondrial ROS-mediated
ferroptosis in metastatic chemoresistant cancers: A call for
investigation. Front Immunol. 15:14289202024. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Ingham J, Ruan JL and Coelho MA: Breaking
barriers: We need a multidisciplinary approach to tackle cancer
drug resistance. BJC Rep. 3:112025. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Dhanyamraju PK: Drug resistance mechanisms
in cancers: Execution of pro-survival strategies. J Biomed Res.
38:95–121. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Reiter RJ, Rosales-Corral SA, Tan DX,
Acuna-Castroviejo D, Qin L, Yang SF and Xu K: Melatonin, a full
service anti-cancer agent: Inhibition of initiation, progression
and metastasis. Int J Mol Sci. 18:8432017. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Li Y, Li S, Zhou Y, Meng X, Zhang JJ, Xu
DP and Li HB: Melatonin for the prevention and treatment of cancer.
Oncotarget. 8:39896–39921. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Putta CL, Eswar K and Rengan AK:
Melatonin: Avenues in cancer therapy and its nanotechnological
advancements. MedComm-Biomater Appl. 2:e582023.PubMed/NCBI
|
|
94
|
Guo R, Rao PG, Liao BZ, Luo X, Yang WW,
Lei XH and Ye JM: Melatonin suppresses PD-L1 expression and exerts
antitumor activity in hepatocellular carcinoma. Sci Rep.
15:84512025. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Mir SM, Aliarab A, Goodarzi G, Shirzad M,
Jafari SM, Qujeq D, Samavarchi Tehrani S and Asadi J: Melatonin: A
smart molecule in the DNA repair system. Cell Biochem Funct.
40:4–16. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Moslehi M, Moazamiyanfar R, Dakkali MS,
Rezaei S, Rastegar-Pouyani N, Jafarzadeh E, Mouludi K, Khodamoradi
E, Taeb S and Najafi M: Modulation of the immune system by
melatonin; implications for cancer therapy. Int Immunopharmacol.
108:1088902022. View Article : Google Scholar : PubMed/NCBI
|
